Complex Endovascular Repair of Paravisceral Infective Native Aortic Aneurysms

Abstract

Objective:

To report the early and mid-term outcome of complex endovascular repair (EVAR) for paravisceral infective native aortic aneurysms (INAA).

Methods:

Interrogation of a prospectively maintained database identified consecutive patients who underwent non-elective complex EVAR for paravisceral INAAs in a single institution between December 2013 and June 2020. All patients were considered to have definite INAAs based on diagnostic criteria. Patients who had prior aortic repair were excluded.

Results:

A total of 26 patients (19 men; mean age 67 years [SD = 11.4]; median diameter 60 mm [IQR: 55–73]) with acute symptomatic (n = 24) or contained ruptured (n = 2) aneurysms underwent surgeon-modified fenestrated EVAR (SM-FEVAR; n = 24) or chimney-periscope EVAR (CHIMPS; n = 2). Median observed follow-up was 36.2 months (18.3–53.5). Nine patients had positive venous blood cultures and a further seven had recent or concomitant infection. All patients received pre- and post-operative antibiotic therapy and rifampicin-soaked endografts. A total of 95 vessels were targeted for preservation and 86 were stent-grafted. One vessel occluded intra-operatively and a further 3 occluded within 30 days. The 30-day/in-hospital mortality was 11.5% (n = 3), and the estimated 1- and 3-year survival (±SD) was 85% ± 7%. Infection-related complications (IRCs) occurred in two patients: both developed new INAA within 30 days of index repair and were treated by EVAR with no mortality. Estimated 3-year freedom from late re-intervention was 100%. One patient required infrarenal EVAR for a non-infective aneurysm at 43 months.

Conclusion:

Complex EVAR for paravisceral INAAs is associated with acceptable early and mid-term outcomes and is an acceptable alternative to open surgery. We propose that these patients are managed with long-term antimicrobials, impregnation of graft material with rifampicin, and rigorous post-operative surveillance.

Clinical Impact

A multi-disciplinary approach is required to deliver the best possible outcome for patients with this challenging aortic pathology.

Keywords

infective native aortic aneurysm paravisceral endovascular repair

Get full access to this article

View all access options for this article.

References

Erbel

Aboyans

Boileau

, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). Eur Heart J 2014; 35:2873-926.

Riambau

Böckler

Brunkwall

, et al. Clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Management of descending thoracic aorta diseases. Eur J Vasc Endovasc Surg. 2017;53:4–52.

Wanhainen

Verzini

Van Herzeele

, et al. European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg. 2019;57:8–93.

Sörelius

Budtz-Lilly

Mani

, et al. Systematic review of the management of mycotic aortic aneurysms. Eur J Vasc Endovasc Surg. 2019;58(3):426–435.

Müller

Wegener

Grabitz

, et al. Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg. 2001;33(1):106–113.

Ting

Cheng

, et al. Surgical treatment of infected aneurysms and pseudoaneurysms of the thoracic and abdominal aorta. Am J Surg. 2005;189:150–154.

Dubois

Daenens

Houthoofd

, et al. Treatment of mycotic aneurysms with involvement of the abdominal aorta: single-centre experience in 44 consecutive cases. Eur J Vasc Endovasc Surg. 2010;40(4):450–456.

Vallejo

Picardo

Bourke

, et al. The changing management of primary mycotic aortic aneurysms. J Vasc Surg. 2011;54(2):334–340.

Hsu

Chang

Chan

, et al. Infected aneurysms of the suprarenal abdominal aorta. J Vasc Surg. 2011;54(4):972–978.

10.

Sedivy

Spacek

El Samman

, et al. Endovascular treatment of infected aortic aneurysms. Eur J Vasc Endovasc Surg. 2012;44:385–394.

11.

Lau

Gaudino

de Biasi

, et al. Outcomes of open repair of mycotic descending thoracic and thoracoabdominal aortic aneurysms. Ann Thorac Surg. 2015;100(5):1712–1717.

12.

Sörelius

Mani

Björck

, et al. Endovascular treatment of mycotic aortic aneurysms: a European multicenter study. Circulation. 2014;130(24):2136–2142.

13.

Sörelius

Wanhainen

Furebring

, et al. Nationwide study of the treatment of mycotic abdominal aortic aneurysms comparing open and endovascular repair. Circulation. 2016;134(23):1822–1832.

14.

Sörelius

Wanhainen

Wahlgren

, et al. Nationwide study on treatment of mycotic thoracic aortic aneurysms. Eur J Vasc Endovasc Surg. 2019;57(2):239–246.

15.

Jorna

Verhoeven

Bos

, et al. Treatment of a ruptured thoracoabdominal aneurysm with a stent-graft covering the celiac axis. J Endovasc Ther. 2006;13(6):770–774.

16.

Kpodonu

Ramaiah

Wheatley

3rd , et al. Customized endoluminal graft to treat a suspected saccular thoracoabdominal mycotic aneurysm. Ann Thorac Surg. 2008;85(4):1463–1465.

17.

Kinney

Kaebnick

Mitchell

, et al. Repair of mycotic paravisceral aneurysm with a fenestrated stent-graft. J Endovasc Ther. 2000;7(3):192–197.

18.

Stanley

Semmens

Lawrence-Brown

, et al. Endoluminal repair of mycotic thoracic aneurysms. J Endovasc Ther. 2003;10(3):511–515.

19.

Clough

Modarai

Bell

, et al. Total endovascular repair of thoracoabdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2012;43(3):262–267.

20.

Scali

Waterman

Feezor

, et al. Treatment of acute visceral aortic pathology with fenestrated/branched endovascular repair in high-surgical-risk patients. J Vasc Surg. 2013;58(1):56–65.

21.

Durgin

Arous

Kumar

, et al. Complete regression of a symptomatic, mycotic juxtarenal abdominal aortic aneurysm after treatment with fenestrated endovascular aneurysm repair. J Vasc Surg. 2016;64(3):803–806.

22.

Tsilimparis

Heidemann

Rohlffs

, et al. Outcome of surgeon-modified fenestrated/branched stent-grafts for symptomatic complex aortic pathologies or contained rupture. J Endovasc Ther. 2017;24:825–832.

23.

Sörelius

Wanhainen

Mani

Infective native aortic aneurysms: call for consensus on definition, terminology, diagnostic criteria, and reporting standards. Eur J Vasc Endovasc Surg. 2020;59(3):333–334.

24.

Juszczak

Vezzosi

Khan

, et al. Endovascular repair of acute juxtarenal and thoracoabdominal aortic aneurysms with surgeon-modified fenestrated endografts. J Vasc Surg. 2020;72(2):435–444.